Metropolis Healthcare Share Price
Sector: Healthcare Facilities
1681.25 -12.85 (-0.76%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1681.25
Today’s High
1702
52 Week Low
1383.70
52 Week High
2306.85
1695.50 +3.20 (0.19%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1685.40
Today’s High
1700.90
52 Week Low
1315
52 Week High
2318.30
Key Metrics
- Market Cap (In Cr) 8709.96
- Beta 0.84
- Div. Yield (%) 0
- P/B 6.59
- TTM P/E 55.28
- Peg Ratio -4.9
- Sector P/E 22.44
- D/E 0
- Open Price 1691.55
- Prev Close 1694.1
Metropolis Healthcare Analysis
Price Analysis
-
1 Week0.54%
-
3 Months6.8%
-
6 Month-16.56%
-
YTD-18.51%
-
1 Year-12.92%
Risk Meter
- 31% Low risk
- 31% Moderate risk
- 31% Balanced Risk
- 31% High risk
- 31% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 5
- 4
- Buy
- 6
- 6
- 6
- 5
- Hold
- 1
- 1
- 1
- 1
- Sell
- 3
- 3
- 3
- 3
- Strong Sell
- 1
- 1
- 1
- 1
- Total
- 16
- 16
- 16
- 14
Metropolis Healthcare News
Stocks to watch: Airtel, Tata Motors, HAL, Cipla among shares in focus today
1 min read . 14 May 2025Hospital chains to report steady growth in Q4, but there are challenges
3 min read . 25 Apr 2025Metropolis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1331.2
- Selling/ General/ Admin Expenses Total
- 313.75
- Depreciation/ Amortization
- 108.68
- Other Operating Expenses Total
- 435.57
- Total Operating Expense
- 1136.89
- Operating Income
- 194.31
- Net Income Before Taxes
- 190.85
- Net Income
- 144.97
- Diluted Normalized EPS
- 28.15
- Period
- 2025
- Total Assets
- 1867.34
- Total Liabilities
- 536.37
- Total Equity
- 1330.97
- Tangible Book Valueper Share Common Eq
- 47.21
- Period
- 2025
- Cashfrom Operating Activities
- 263.24
- Cashfrom Investing Activities
- -201.06
- Cashfrom Financing Activities
- -86.63
- Net Changein Cash
- -23.14
- Period
- 2024
- Total Revenue
- 1207.71
- Selling/ General/ Admin Expenses Total
- 637.15
- Depreciation/ Amortization
- 94.47
- Other Operating Expenses Total
- 5.74
- Total Operating Expense
- 1009.7
- Operating Income
- 198.01
- Net Income Before Taxes
- 174.69
- Net Income
- 127.82
- Diluted Normalized EPS
- 24.87
- Period
- 2024
- Total Assets
- 1555.06
- Total Liabilities
- 458.91
- Total Equity
- 1096.16
- Tangible Book Valueper Share Common Eq
- 49.8
- Period
- 2024
- Cashfrom Operating Activities
- 263.56
- Cashfrom Investing Activities
- -89.41
- Cashfrom Financing Activities
- -181.2
- Net Changein Cash
- -6.22
- Period
- 2023
- Total Revenue
- 1148.21
- Selling/ General/ Admin Expenses Total
- 575.25
- Depreciation/ Amortization
- 89.22
- Other Operating Expenses Total
- 5.77
- Total Operating Expense
- 944.64
- Operating Income
- 203.57
- Net Income Before Taxes
- 187.5
- Net Income
- 142.88
- Diluted Normalized EPS
- 27.83
- Period
- 2023
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022
- Total Revenue
- 1228.34
- Selling/ General/ Admin Expenses Total
- 585.21
- Depreciation/ Amortization
- 63.22
- Other Operating Expenses Total
- 1.73
- Total Operating Expense
- 930.99
- Operating Income
- 297.35
- Net Income Before Taxes
- 293.35
- Net Income
- 214.18
- Diluted Normalized EPS
- 39.43
- Period
- 2022
- Total Assets
- 1530.29
- Total Liabilities
- 644.1
- Total Equity
- 886.2
- Tangible Book Valueper Share Common Eq
- 13.72
- Period
- 2022
- Cashfrom Operating Activities
- 253.27
- Cashfrom Investing Activities
- -737.57
- Cashfrom Financing Activities
- 162.52
- Net Changein Cash
- -323.14
- Period
- 2021
- Total Revenue
- 997.99
- Selling/ General/ Admin Expenses Total
- 436.9
- Depreciation/ Amortization
- 45.94
- Other Operating Expenses Total
- 2.62
- Total Operating Expense
- 755.08
- Operating Income
- 242.91
- Net Income Before Taxes
- 244.32
- Net Income
- 183.1
- Diluted Normalized EPS
- 35.79
- Period
- 2021
- Total Assets
- 1004.42
- Total Liabilities
- 297.81
- Total Equity
- 706.6
- Tangible Book Valueper Share Common Eq
- 113.83
- Period
- 2021
- Cashfrom Operating Activities
- 249.03
- Cashfrom Investing Activities
- 61.7
- Cashfrom Financing Activities
- -32.69
- Net Changein Cash
- 279.42
- Period
- 2020
- Total Revenue
- 856.41
- Selling/ General/ Admin Expenses Total
- 415.95
- Depreciation/ Amortization
- 39.27
- Other Operating Expenses Total
- 4.68
- Total Operating Expense
- 686.77
- Operating Income
- 169.63
- Net Income Before Taxes
- 168.73
- Net Income
- 127.33
- Diluted Normalized EPS
- 25.84
- Period
- 2020
- Total Assets
- 752.23
- Total Liabilities
- 228.74
- Total Equity
- 523.5
- Tangible Book Valueper Share Common Eq
- 79.99
- Period
- 2020
- Cashfrom Operating Activities
- 215
- Cashfrom Investing Activities
- -104.83
- Cashfrom Financing Activities
- -55.32
- Net Changein Cash
- 55.8
- Period
- 2019
- Total Revenue
- 761.18
- Selling/ General/ Admin Expenses Total
- 365.89
- Depreciation/ Amortization
- 20.07
- Other Operating Expenses Total
- 4.79
- Total Operating Expense
- 580.84
- Operating Income
- 180.34
- Net Income Before Taxes
- 186.55
- Net Income
- 120.15
- Diluted Normalized EPS
- 24.01
- Period
- 2019
- Total Assets
- 552.64
- Total Liabilities
- 134.1
- Total Equity
- 418.54
- Tangible Book Valueper Share Common Eq
- 63.1
- Period
- 2019
- Cashfrom Operating Activities
- 90.15
- Cashfrom Investing Activities
- 35.34
- Cashfrom Financing Activities
- -118.15
- Net Changein Cash
- 7.9
- Period
- 2025-03-31
- Total Revenue
- 345.29
- Selling/ General/ Admin Expenses Total
- 82.19
- Depreciation/ Amortization
- 28.62
- Other Operating Expenses Total
- 127.21
- Total Operating Expense
- 311.62
- Operating Income
- 33.67
- Net Income Before Taxes
- 36.04
- Net Income
- 29.14
- Diluted Normalized EPS
- 5.69
- Period
- 2025-03-31
- Total Assets
- 1867.34
- Total Liabilities
- 536.37
- Total Equity
- 1330.97
- Tangible Book Valueper Share Common Eq
- 47.21
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 263.24
- Cashfrom Investing Activities
- -201.06
- Cashfrom Financing Activities
- -86.63
- Net Changein Cash
- -23.14
- Period
- 2024-12-31
- Total Revenue
- 322.77
- Selling/ General/ Admin Expenses Total
- 81.43
- Depreciation/ Amortization
- 27.7
- Other Operating Expenses Total
- 102.38
- Total Operating Expense
- 278.45
- Operating Income
- 44.31
- Net Income Before Taxes
- 42.34
- Net Income
- 31.36
- Diluted Normalized EPS
- 6.09
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 349.79
- Selling/ General/ Admin Expenses Total
- 78.44
- Depreciation/ Amortization
- 26.82
- Other Operating Expenses Total
- 108.94
- Total Operating Expense
- 286.73
- Operating Income
- 63.06
- Net Income Before Taxes
- 61.4
- Net Income
- 46.52
- Diluted Normalized EPS
- 9.03
- Period
- 2024-09-30
- Total Assets
- 1631.23
- Total Liabilities
- 447.29
- Total Equity
- 1183.94
- Tangible Book Valueper Share Common Eq
- 67.72
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 122.47
- Cashfrom Investing Activities
- -98.62
- Cashfrom Financing Activities
- -41.91
- Net Changein Cash
- -18.23
- Period
- 2024-06-30
- Total Revenue
- 313.36
- Selling/ General/ Admin Expenses Total
- 71.69
- Depreciation/ Amortization
- 25.54
- Other Operating Expenses Total
- 97.04
- Total Operating Expense
- 260.08
- Operating Income
- 53.27
- Net Income Before Taxes
- 51.08
- Net Income
- 37.95
- Diluted Normalized EPS
- 7.37
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 331
- Selling/ General/ Admin Expenses Total
- 71.47
- Depreciation/ Amortization
- 26.42
- Other Operating Expenses Total
- 106.2
- Total Operating Expense
- 277.44
- Operating Income
- 53.56
- Net Income Before Taxes
- 50.53
- Net Income
- 36.41
- Diluted Normalized EPS
- 7.09
- Period
- 2024-03-31
- Total Assets
- 1555.06
- Total Liabilities
- 458.91
- Total Equity
- 1096.16
- Tangible Book Valueper Share Common Eq
- 49.8
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 263.56
- Cashfrom Investing Activities
- -89.41
- Cashfrom Financing Activities
- -181.2
- Net Changein Cash
- -6.22
- Period
- 2023-12-31
- Total Revenue
- 291.12
- Selling/ General/ Admin Expenses Total
- 69.51
- Depreciation/ Amortization
- 24.99
- Other Operating Expenses Total
- 97.42
- Total Operating Expense
- 251.26
- Operating Income
- 39.86
- Net Income Before Taxes
- 36.85
- Net Income
- 27.16
- Diluted Normalized EPS
- 5.28
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Metropolis Healthcare Technical
Moving Average
SMA
- 5 Day1701.48
- 10 Day1704.96
- 20 Day1694.84
- 50 Day1685.89
- 100 Day1690.58
- 300 Day1902.74
Metropolis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rainbow Childrens Medicare
- 1514.65
- 4.7
- 0.31
- 1708.5
- 1079.25
- 15436.01
- Vijaya Diagnostic Centre
- 992.75
- -5.65
- -0.57
- 1276.75
- 725.4
- 10204.3
- Metropolis Healthcare
- 1681.25
- -12.85
- -0.76
- 2306.85
- 1383.7
- 8709.96
- Healthcare Global Enterprises
- 544.95
- -1.45
- -0.27
- 636.8
- 345.25
- 7563.86
- Kovai Medical Cente And Hospital
- 5755.05
- -70.15
- -1.2
- 6400
- 4067.5
- 6322.51
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rainbow Childrens Medicare
- 61.52
- 10.18
- 19.73
- 15.21
- Vijaya Diagnostic Centre
- 69.03
- 12.46
- 21.09
- 21.54
- Metropolis Healthcare
- 60.68
- 6.65
- 17.66
- 13.79
- Healthcare Global Enterprises
- 172.12
- 8.17
- -0.46
- -0.9
- Kovai Medical Cente And Hospital
- 30.46
- 5.86
- 19.69
- 13.18
Metropolis Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 0.58%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 13-May-25
- Audited Results
- 04-Feb-25
- Quarterly Results
- 09-Dec-24
- Preferential issue of shares
- 08-Nov-24
- Quarterly Results
- 10-Aug-24
- Quarterly Results
- 21-May-24
- Audited Results
- 02-Feb-24
- Quarterly Results
- 04-Nov-23
- Quarterly Results & Interim Dividend
- 02-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results
- Meeting Date
- Announced on
- Purpose
- 16-Jun-25
- 16-May-25
- POM
- 11-Feb-25
- 10-Jan-25
- POM
- 21-Aug-24
- 31-Jul-24
- AGM
- 30-Oct-23
- 28-Sept-23
- POM
- 17-Aug-23
- 24-Jul-23
- AGM
- 11-Aug-21
- 05-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 06-Nov-23
- 17-Nov-23
- 17-Nov-23
- 4
- 07-Feb-23
- 23-Feb-23
- 23-Feb-23
- 8
- 03-Feb-22
- 22-Feb-22
- 21-Feb-22
- 8
- 04-Feb-21
- 19-Feb-21
- 17-Feb-21
- 8


